Abstract
A new sensitiser (4) for use in photodynamic therapy (PDT) has beendeveloped to enable control of ROS production as a function of pH.This pH dependent PDT behaviour was tested in HeLa cells and in SCIDmice bearing human xenograft pancreatic cancer (BxPC-3) tumours.
| Original language | English |
|---|---|
| Pages (from-to) | 16832-16835 |
| Number of pages | 4 |
| Journal | Chemical Communications |
| Volume | 15 |
| Early online date | 30 Sept 2015 |
| DOIs | |
| Publication status | Published (in print/issue) - 7 Dec 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- PDT
- ROS
- sensitiser
- pH-controlled
Fingerprint
Dive into the research topics of 'Modulation of ROS production in photodynamic therapy using a pH controlled photoinduced electron transfer (PET) based sensitiser'. Together they form a unique fingerprint.Profiles
-
Anthony McHale
- School of Pharm. & Pharmaceut. Sc. - Professor of Medical Biotechnology
- Faculty Of Life & Health Sciences - Full Professor
- Biomedical Sciences Research
Person: Academic
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver